Nuclear Threat Initiative

The Nuclear Threat Initiative (NTI) is an American non-profit organization based in Washington, D.C. It was founded in January 2001 by Senator Sam Nunn and media mogul Ted Turner.¹⁾

The current CEO is Ernest Moniz, whose previous positions include US Secretary of Energy and Professor of Physics and Engineering at MIT. Among NTI’s advisors and directors are many prominent philanthropists, former politicians and experts.17 Connections to influential policymakers do not guarantee that NTI will influence policy in this space, but speaks to the organisation’s strong reputation.

NTI’s biosecurity efforts are led by Dr. Beth Cameron. Dr. Cameron previously served as the Senior Director for Global Health Security and Biodefense on the White House National Security Council (NSC) staff. She also worked on Cooperative Threat Reduction in the Department of Defense and Global Threat Reduction in the Department of State. Other members of NTI | bio’s team include;

• Andrew Hebbeler, who was previously Deputy Director of the U.S. Department of State's Office of Science and Technology Cooperation and a Senior Science, Technology, and Innovation Adviser to the Secretary of State
• Jaime Yassif, who previously worked as a Program Officer at Open Philanthropy, where she led the initiative on Biosecurity and Pandemic Preparedness
• Jessica Bell, previously Senior Advisor to the Defense Threat Reduction Agency’s Cooperative Threat Reduction (CTR) program
• Jacob Eckles, previously a Global Health Officer in the Office of Global Affairs at the U.S. Department of Health and Human Services
• Hayley Severance, previously Senior Policy Advisor in the Office of the Deputy Assistant Secretary of Defense for Countering Weapons of Mass Destruction at the U.S. Department of Defense.

NTI | bio is also advised by a prestigious Advisory Group headed by Margaret Hamburg, Foreign Secretary of the National Academy of Medicine. Overall, NTI | bio’s staff bring a wealth of past policy experience in influential positions. They seem well-placed to lead future efforts to reduce biosecurity risks.²⁾

The Nuclear Threat Initiative (NTI) was founded in January 2001 as a result of concerns expressed to former Senator Sam Nunn in the spring of 2000 by CNN founder R. E. Ted Turner that “the threat from nuclear weapons had fallen off most people's radar screens after the end of the Cold War.”

Turner asked Nunn's assistance in assessing “whether a private organization could make a difference.” NTI is “supported by a pledge from Mr. Turner and other private contributions.” NTI has obligated more than $37 million in program awards and grants.³⁾

=== Other Patrons Nuclear Threat Initiative - MacArthur Foundation www.macfound.org/grantee/nuclear-threat-initiative-38211 Washington, D.C. www.nti.org. Nuclear Threat Initiative was awarded $13,795,600 between 2004 and 2021, including 13 grants in Nuclear Challenges.

Strengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats

On March 2021, the Nuclear Threat Initiative (NTI) partnered with the Munich Security Conference (MSC) to conduct a tabletop exercise on reducing high-consequence biological threats. Conducted virtually, the exercise examined gaps in national and international biosecurity and pandemic preparedness architectures and explored opportunities to improve capabilities to prevent and respond to high-consequence biological events. Participants included 19 senior leaders and experts from across Africa, the Americas, Asia, and Europe with decades of combined experience in public health, biotechnology industry, international security, and philanthropy.

The exercise scenario portrayed a deadly, global pandemic involving an unusual strain of monkeypox virus that emerged in the fictional nation of Brinia and spread globally over 18 months. Ultimately, the exercise scenario revealed that the initial outbreak was caused by a terrorist attack using a pathogen engineered in a laboratory with inadequate biosafety and biosecurity provisions and weak oversight. By the end of the exercise, the fictional pandemic resulted in more than three billion cases and 270 million fatalities worldwide.

• Discussion among exercise participants led to the following key findings:
• • Weak global detection, assessment, and warning of pandemic risks. The international
• community needs a more robust, transparent detection, evaluation, and early warning system
• that can rapidly communicate actionable information about pandemic risks.
• • Gaps in national-level preparedness. National governments should improve preparedness by
• developing national-level pandemic response plans built upon a coherent system of “triggers”
• that prompt anticipatory action, despite uncertainty and near-term costs—in other words, on a
• “no-regrets” basis.
• • Gaps in biological research governance. The international system for governing dual-use
• biological research is neither prepared to meet today’s security requirements, nor is it ready for
• significantly expanded challenges in the future. There are risk reduction needs throughout the
• bioscience research and development life cycle.
• • Insufficient financing of international preparedness for pandemics. Many countries around
• the world lack financing to make essential national investments in pandemic preparedness.
• To address these findings, the authors developed the following recommendations.
• 1 Bolster international systems for pandemic risk assessment, warning, and investigating outbreak
• origins
• • The WHO should establish a graded, transparent, international public health alert system.
• • The United Nations (UN) system should establish a new mechanism for investigating high-
• consequence biological events of unknown origin, which we refer to as a “Joint Assessment
• Mechanism.”
• NTI Paper 7 www.nti.org
• 2 Develop and institute national-level triggers for early, proactive pandemic response
• • National governments must adopt a “no-regrets” approach to pandemic response, taking
• anticipatory action—as opposed to reacting to mounting case counts and fatalities, which are
• lagging indicators.
• • To facilitate anticipatory action on a no-regrets basis, national governments should develop
• national-level plans that define and incorporate “triggers” for responding to high-consequence
• biological events. (More about “triggers” is found on page 17.)
• 3 Establish an international entity dedicated to reducing emerging biological risks associated with
• rapid technology advances
• • The international community should establish an entity dedicated to reducing the risk of
• catastrophic events due to accidents or deliberate abuse of bioscience and biotechnology.
• • To meaningfully reduce risk, the entity should support interventions throughout the bioscience
• and biotechnology research and development life cycle—from funding, through execution, and on
• to publication or commercialization.
• 4 Develop a catalytic global health security fund to accelerate pandemic preparedness capacity
• building in countries around the world
• • National leaders, development banks, philanthropic donors, and the private sector should
• establish and resource a new financing mechanism to bolster global health security and pandemic
• preparedness.
• • The design and operations of the fund should be catalytic—incentivizing national governments to
• invest in their own preparedness over the long term.
• 5 Establish a robust international process to tackle the challenge of supply chain resilience
• • The UN Secretary-General should convene a high-level panel to develop recommendations for
• critical measures to bolster global supply chain resilience for medical and public health supplies.
• This report is organized into three parts: the first is a description of the exercise design and scenario;
• the second is a summary of the exercise discussions and related findings; and the third is a set of
• recommendations developed by the authors to address the identified gaps and requirements. NTI developed
• these recommendations after the event concluded; participants were not involved in their development
• and have not been asked to endorse them. The appendices provide a list of the experts who supported the
• exercise development process (Appendix A) as well as technical details about the epidemiological model
• (Appendix B) used to inform this fictional monkeypox pandemic scenario. ⁴⁾

May 20, 2022 Monkeypox is the new COVID Let's watch all these media and national security goons shift gears again

A New Plague to Fear

Isn’t it rather convenient that just after everything started winding down and it looked like COVID-19 was due to become just another endemic flu, a few people out of billions potentially immunocompromised by vaccines just happen to start contracting and sustaining human-to-human transmission of zoonotic illnesses like Monkeypox and Hemorrhagic fever hantavirus that ordinarily have poor transmissibility?

What is Monkeypox, the Virus Infecting People in the U.S. and Europe?

Monkeypox isn’t a new disease. The first confirmed human case was in 1970, when the virus was isolated from a child suspected of having smallpox in the Democratic Republic of Congo (DRC). Monkeypox is unlikely to cause another pandemic, but with COVID-19 top of mind, fear of another major outbreak is understandable. Though rare and usually mild, monkeypox can still potentially cause severe illness. Health officials are concerned that more cases will arise with increased travel.

If it does turn into another pandemic, they'll probably start having people take Jynneos or ACAM2000;

Bavarian Nordic scores FDA nod for smallpox and monkeypox vaccine Jynneos

Sep 25, 2019 07:35am

Bavarian Nordic and the U.S. government have been working for years to advance a next-gen smallpox vaccine, and now the company has scored its much-anticipated approval. The vaccine, Jynneos, represents the first non-replicating smallpox vaccine in the U.S. and the first monkeypox vaccine worldwide.

Importantly, Jynneos is also the first smallpox vaccine for people with compromised immune systems, such as people with eczema, and addresses a long-running U.S. goal to be able to provide the full population with protection. Bavarian Nordic CEO Paul Chaplin said on a Wednesday conference call the vaccine is the “result of a fifteen-year partnership” between the U.S. government and the company.

The ACAM2000 made by Emergent BioSolutions The same Emergent BioSolutions that received preferential contracts for COVID-19 vaccines from Robert Kadlec because of the enduring partnership between Robert Kadlec and the late Fuad El-Hibri, in spite of Emergent BioSolutions' poor quality control..

The same Emergent BioSolutions that renamed themselves from BioPort, after the Anthrax vaccine fiasco that occurred right after Amerithrax. There is some evidence that Gulf War Syndrome is linked to anthrax vaccines; ⁵⁾

=== Dr Malone Monkey Pox Truth versus Fearporn ===.

Substack May 20, 2022 - Robert W Malone MD, MS

I keep getting asked the same question again and again; is this outbreak of monkey pox a real threat, or is this another case of overstated and weaponized public health messaging? I am going to save my answer to this question for the end of this article and instead focus on what monkey pox is, the nature and characteristics of the associated disease, what we know and don’t know.

The monkeypox virus, which originates in various regions of Africa, is related to SmallPox (Variola), which are both members of the genus Orthopoxvirus. However, it is important to understand that Variola (major or minor) is the species of virus which is responsible for the worst human disease caused by the Orthopox viruses. For example, Cowpox, Horsepox, and Camelpox are also members of this genus, none of which are a major health threat to humans, and one of which (Cowpox) has even been (historically) used as a Smallpox vaccine. My point is that just because Monkeypox is related to Smallpox, this does not in any way mean that it represents a similar public health threat. Anyone who implies otherwise is basically engaged in or otherwise supporting weaponized public health-related propaganda. In other words, spreading public health fearporn.

Monkeypox was first identified in 1958 in colonies of monkeys, and the first human case of the virus was identified in 1970 in the Democratic Republic of the Congo. Most likely this was just the first case identified, as people living in Africa have been in contact with monkeys and the other Monkeypox animal hosts for millennia. The “West African” monkeypox clade (clade = variant) circulating outside of Africa at this time causes a milder disease compared to the closely related virus found found in other regions of Africa (Congo clade).

The symptoms of monkeypox are somewhat similar to, but much milder than smallpox disease. The general clinical presentation of the disease caused by the West African monkey pox clade virus involves Influenza-like symptoms — fever, body aches, chills — together with swollen lymph nodes. A rash on the palm of the hand is often observed.⁶⁾

Monkeypox Was a Table-Top Simulation Only Last Year By Michael Senger May 20, 2022 (random sections)

Elite media outlets around the world are on red alert over the world’s first-ever global outbreak of Monkeypox in mid-May 2022—just one year after an international biosecurity conference in Munich held a simulation of a “global pandemic involving an unusual strain of Monkeypox” beginning in mid-May 2022.

Monkeypox was first identified in 1958, but there’s never been a global Monkeypox outbreak outside of Africa until now—in the exact week of the exact month predicted by the biosecurity folks in their pandemic simulation. Take these guys to Vegas!

Ed Yong, who’s penned dozens of hysterical articles on Covid for The Atlantic including such gems as COVID-19 Long-Haulers Are Fighting for Their Future, Even Health-Care Workers With Long COVID Are Being Dismissed, How Did This Many Deaths Become Normal? and The Final Pandemic Betrayal, is hot on the scene of the new Monkeypox outbreak.

Eric Feigl-Ding is also all over this.

The global Monkeypox outbreak—occurring on the exact timeline predicted by a biosecurity simulation of a global Monkeypox outbreak a year prior—bears a striking resemblance to the outbreak of COVID-19 just months after Event 201, a simulation of a coronavirus pandemic almost exactly like COVID-19.

Event 201 was hosted in October 2019—just two months before the coronavirus was first revealed in Wuhan—by the Gates Foundation, the World Economic Forum, Bloomberg, and Johns Hopkins. As with the Event 201, the participants at the Monkeypox simulation have thus far been stone silent as to their having participated in a pandemic simulation the facts of which happened to come true in real life just months later.

One person who was present at both Event 201 and the Monkeypox simulation is George Fu Gao, director of the Chinese Center for Disease Control. At event 201, Gao specifically raised the point of countering “misinformation” during a “hypothetical” coronavirus pandemic.⁷⁾⁸⁾

The dangers of monkeypox to humans

By The Los Angeles Times - September 28, 2010

Most vertebrate animal species have some sort of poxvirus capable of causing severe illness. These ancient pathogens have evolved within and among vertebrates since the dawn of life.

In one of public health’s greatest triumphs, our own orthopox virus — smallpox, or Variola — was eradicated by 1980. Because chickenpox isn’t a true poxvirus, humans don’t have a poxvirus of their own anymore.

Now, however, some researchers are concerned that another orthopox virus, monkeypox, may be adapting to fill the void. Currently, monkeypox can spread to humans fairly easily if they come into contact with an infected animal. It doesn’t always spread from human to human. But that could change.

There are two distinct genetic lines of monkeypox. The less severe West African strain entered the United States in 2003 in the body of an infected Gambian pouched rat. It spread in a pet store to dormice and to caged prairie dogs, and eventually caused 81 human infections, none of them serious and none of which spread. The far deadlier Congo basin strain causes a disease that is “virtually indistinguishable” from typical smallpox, says virologist Mark Buller of St. Louis University.⁹⁾

* White Rose Wiki